ICAD 2006: The 10th International Conference on AD and Related Disorders

ICAD 2006：第十届 AD 及相关疾病国际会议

• 批准号: 7162840
• 负责人: WILLAIM H THIES
• 金额: $ 4万
• 依托单位: ALZHEIMER'S ASSOCIATION
• 依托单位国家: 美国
• 财政年份: 2006
• 资助国家: 美国
• 起止时间: 2006-07-01 至 2007-06-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7162840
• 关键词: Alzheimer' s disease; meeting /conference /symposium; travel

DESCRIPTION (provided by applicant): Alzheimer's disease is 1 of the major areas of research in neuroscience. There has been a tremendous increase in the rate of excellent publications on Alzheimer's disease and related disorders. The International Conference on Alzheimer's Disease and Related Disorders started in 1988 in Las Vegas, Nevada and attracted over 350 scientists from around the world. Over the years it has grown significantly--1990, Toronto, Canada (750); 1992, Padova, Italy (1,000); 1994, Minneapolis, Minnesota (1,220); 1996, Osaka, Japan (1,600); 1998, Amsterdam, Netherlands (2,500); 2000, Washington, DC (3,000); 2002, Stockholm, Sweden (3,800); Philadelphia, Pennsylvania (4,500)--and has become THE conference on Alzheimer's disease and related disorders research. Since the last conference in Philadelphia, important advances continue to take place regarding etiology, clinical course, differential diagnosis, epidemiology and risk factors, histopathological course, genetics, molecular genetics, model systems, therapeutics and related neurodegeneration. This application specifically requests funds to help support the cost of travel for talented junior investigators, who will be selected on a competitive basis. The funding of this application will make a major contribution to the success of this international conference and the advancement of research, specifically by allowing support to be provided to a higher percentage of young researchers.

描述（由申请人提供）：阿尔茨海默病是神经科学研究的主要领域之一。关于阿尔茨海默病及相关疾病的优秀出版物的数量大幅增加。阿尔茨海默病及相关疾病国际会议于 1988 年在内华达州拉斯维加斯召开，吸引了来自世界各地的 350 多名科学家参加。多年来它已经显着增长——1990 年，加拿大多伦多 (750)； 1992 年，意大利帕多瓦（1,000 名）； 1994 年，明尼苏达州明尼阿波利斯 (1,220)； 1996 年，日本大阪（1,600 人）； 1998 年，荷兰阿姆斯特丹（2,500 人）； 2000 年，华盛顿特区（3,000）； 2002 年，瑞典斯德哥尔摩（3,800 名）；宾夕法尼亚州费城 (4,500)——已成为阿尔茨海默病及相关疾病研究的权威会议。自上次在费城举行的会议以来，在病因学、临床过程、鉴别诊断、流行病学和危险因素、组织病理学过程、遗传学、分子遗传学、模型系统、治疗学和相关神经变性方面继续取得重要进展。该申请特别要求资金来帮助支持有才华的初级研究人员的旅行费用，这些研究人员将在竞争的基础上被选拔。该申请的资助将为本次国际会议的成功和研究的进步做出重大贡献，特别是为更高比例的年轻研究人员提供支持。